Ganjam launches new skin test to tackle TB cases
2
3
Berhampur: Ganjam administration has introduced the
Cy-TB test
to detect latent infections under the
National Tuberculosis Elimination Programme
(NTEP).
"This will enable the breaking of the chain of the disease before its infection stage," said Bhabani Shankar Mishra, chief district medical officer (CDMO), while launching the new test here on Wednesday.
He said the test is exclusively designed to detect TB infection among vulnerable groups, which will help in early detection and break the chain of its spread.
These include household contacts of TB patients, diabetics, smokers, malnourished individuals and citizens above 60 years of age. "When we focus on these vulnerable groups, it will help to break the chain of infection," said Abani Kumar Patra, district TB officer.
Bideshi Jena, district TB programme coordinator, added that the Cy-TB test reflects a strategic govt push for early detection. The district has received 3,500 vials, distributed to various community health centres (CHCs), for the test. On the first day alone, about 1,100 people were tested.
Tuberculosis remains a serious public health challenge in Ganjam, with 280 deaths reported in 2024 and over 6,500 new cases. The district reported 6,698 new cases in 2023 and 6,466 in 2022, with 224 and 319 deaths, respectively.
The govt has introduced a new 26-week BPaLM treatment regimen for multi-drug-resistant TB (MDR-TB). The shorter course has been launched at three major medical colleges — MKCG Medical College and Hospital, Berhampur, SCB Medical College and Hospital, Cuttack and PRM Medical College and Hospital, Baripada.
Berhampur: Ganjam administration has introduced the Cy-TB test to detect latent infections under the National Tuberculosis Elimination Programme (NTEP).
"This will enable the breaking of the chain of the disease before its infection stage," said Bhabani Shankar Mishra, chief district medical officer (CDMO), while launching the new test here on Wednesday.
He said the test is exclusively designed to detect TB infection among vulnerable groups, which will help in early detection and break the chain of its spread.
These include household contacts of TB patients, diabetics, smokers, malnourished individuals and citizens above 60 years of age. "When we focus on these vulnerable groups, it will help to break the chain of infection," said Abani Kumar Patra, district TB officer.
Bideshi Jena, district TB programme coordinator, added that the Cy-TB test reflects a strategic govt push for early detection. The district has received 3,500 vials, distributed to various community health centres (CHCs), for the test. On the first day alone, about 1,100 people were tested.
Tuberculosis remains a serious public health challenge in Ganjam, with 280 deaths reported in 2024 and over 6,500 new cases. The district reported 6,698 new cases in 2023 and 6,466 in 2022, with 224 and 319 deaths, respectively.
The govt has introduced a new 26-week BPaLM treatment regimen for multi-drug-resistant TB (MDR-TB). The shorter course has been launched at three major medical colleges — MKCG Medical College and Hospital, Berhampur, SCB Medical College and Hospital, Cuttack and PRM Medical College and Hospital, Baripada.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
10 hours ago
- Hans India
3 die of diarrhoea in Ganjam
Berhampur: Suspected diarrhoea has claimed the lives of three persons and affected several others in at least four villages in Ganjam district, officials said on Wednesday. The casualties were reported from Damapur village under Sanakhemundi block, when several villagers began showing symptoms such as vomiting and loose motion, according to the district health department. According to officials, Sambaru Mallick (63) and Kandara Mallick (60) died at their homes on Monday, while Sukura Mallick (45) passed away on Tuesday night at MKCG Medical College and Hospital, where she was undergoing treatment. At least seven others have been affected by the water-borne disease, four of whom are currently admitted at MKCG Hospital, while others were initially treated at Digapahandi Community Health Centre. Chief District Medical Officer (CDMO) Sukant Kumar Nayak said the exact cause of the deaths is still being determined, and laboratory reports are awaited. Health teams have been deployed, and a temporary health camp has been set up in the village. Health officials have collected stool and water samples for testing and launched an awareness campaign urging villagers to consume boiled water and maintain hygiene. Water sources have been disinfected, and halogen tablets along with ORS packets have been distributed.
Indian Express
11 hours ago
- Indian Express
Breaking the TB chain
With the aim of making clinical testing for a wider range of diseases more accessible, the Indian Council of Medical Research (ICMR) has updated its National List of Essential Diagnostics to include rapid diagnostic tests for sickle cell anaemia, thalassaemia, Hepatitis B and syphilis, among others. Significantly, there is a push for early detection of tuberculosis (TB) at the lower levels of the healthcare system — the list recommends collecting samples at the level of the sub health centre (SHC) for molecular TB testing in order to identify asymptomatic individuals, as well as the TB skin test in community healthcare centres, to detect the presence of the pathogen in those without an active infection. WHO data shows that since 2015, India has made good progress in tackling TB. There has been a 17 per cent drop in the number of reported cases and a 20 per cent drop in the number of deaths. More than 85 per cent of those detected with the infection have received treatment and efforts to contain multi-drug-resistant TB are yielding results. It is evident that the TB problem is not intractable, but given India's massive disease burden, accounting for 27 per cent of the global cases, there is no room for complacency. The challenge is compounded by the problem of subclinical TB, where infected individuals do not yet present symptoms like persistent coughing. A study published in The International Journal of Tuberculosis and Lung Disease in 2024 found that 39 per cent of TB cases in India are subclinical, and therefore more likely to escape detection and continue spreading. This is why the attempt to tackle TB as early as possible matters. The ICMR's update, making molecular TB testing available at the level of the community health centre (CHC) —with sub-centres and primary healthcare centres (PHCs) also sending samples to be tested — could be crucial to providing timely treatment and breaking the chain of transmission. Despite making significant progress, India is unlikely to meet its target of eliminating TB by the end of the year. The government has made the expansion of primary healthcare a key pillar of its policy, with the aim of bringing a broad spectrum of services closer to the people through the network of over 1.7 lakh centres around the country. The broadening of the TB diagnostics must be factored in, equipping SHCs and PHCs to identify and treat infected individuals as early as possible, even as initiatives to reduce the financial burden of treatment and improve access to nutrition are strengthened.
Time of India
2 days ago
- Time of India
Gadkari inaugurates daycare facility for infectious diseases at city hospital
1 2 3 4 Nagpur: Ishra Health, formerly known as Tayade's Clinic, has introduced a daycare facility for infectious disease treatment at its newly upgraded facility in Nagpur. The facility was inaugurated by Union minister Nitin Gadkari recently. The centre is equipped with modern amenities, and well-trained staff. Dr Ashwini Tayade heads the department of infectious diseases. Tayade specialises in the diagnosis and treatment of complex infectious diseases including HIV, Tuberculosis (TB), and infection-related cancers. Ishra Health also offers advanced cancer care services under the leadership of Dr Ramakant Tayade, onco-surgeon with a career spanning over two decades. Dr Ramakant Tayade specialises in the surgical treatment of breast cancer, oral, head and neck cancers, thyroid cancer, gastrointestinal and colorectal cancers, esophagus and pancreatico-biliary cancers, and gynaecological malignancies.
